-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

A Violent Graft in a Vulnerable Host: The Future of aGVHD Management

Sponsor: an independent educational grant from CSL Behring LLC. Provided by RMEI Medical Education, LLC.
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Hodgkin lymphoma, MDS, Non-Hodgkin lymphoma, MPN, B Cell lymphoma, CML, GVHD, T Cell lymphoma, CMML, Diseases, Immune Disorders, Indolent lymphoma, Aggressive lymphoma
Friday, December 6, 2024: 11:00 AM-2:00 PM
Room 29 (San Diego Convention Center)
Chair:
Sung W. Choi, MD, MS, University of Michigan
Disclosures:
No relevant conflicts of interest to declare.
Speakers:
Chelsea Honstain, MS, FNP-C, University of Michigan Health , Gianni Scappaticci, University of Michigan and Paul Campbell, Patient Speaker
Disclosures:
No relevant conflicts of interest to declare.
In this activity, an interprofessional expert panel discusses the role of the interprofessional care team in the prophylaxis and management of acute graft-versus-host disease (aGVHD) according to current guidelines and available agents. The panel will also discuss emerging novel therapies for aGVHD prevention and treatment and hear from an experienced patient.